Estée Lauder
No proof required
Up to $5,000
Claims opening soon
GlaxoSmithKline
Class action for Canadians who suffered adverse cardiovascular events from diabetes drugs Avandia, Avandamet, or Avandaryl.
ClosedOntario, QuebecClaim status: Claim window closedPayout: Closed settlementNo longer claimable
About this settlement
A lawsuit for people who used certain diabetes drugs and suffered serious heart-related side effects.
This settled class action involved claims against GlaxoSmithKline for adverse cardiovascular events linked to the diabetes drugs Avandia, Avandamet, and Avandaryl (rosiglitazone) used in Canada since 2000. The claim period is closed, but affected individuals can review information and past documents online.
Who qualifies
- Persons residing in Canada who took or purchased rosiglitazone drugs (Avandia, Avandamet, Avandaryl) since March 21, 2000.
- Includes family members, successors, assigns, and dependants.
- Includes a subclass for residents of Quebec.
Closed settlement
Claim status: Claim window closed
Audible
No proof required
Compensation pending
Claims opening soon
Government of Canada
Proof required
Up to $200,000
647 days left
Meta (Facebook)
No proof required
Up to $90
Claims opening soon
Ticketmaster
No proof required
Compensation pending
Claims opening soon
Apple
No proof required
Up to $100
Claims opening soon